Automotive & EV

Xpeng committed to Australia despite TrueEV court battle

28 sec read5 views0 listens

Xpeng, an EV brand launched in Australia in 2024 under TrueEV, is facing a legal battle after deciding to establish its own factory distribution, leading to customer trust issues and a Federal Court trial. Despite this, Xpeng remains committed to the Australian market, planning to introduce five new models within six months and focusing on building out its retail network and AI products to demonstrate long-term commitment.

Read the full article at CarExpert

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Almost Half of Americans View SCOTUS as Political

The Supreme Court of the United States (SCOTUS) has a process in place for correcting errors in its opinions, which can include minor typographical mistakes and more substantive changes. Here are some key points about this revision process: The Revis...

Ali Nemati

Ecommerce RetailJun 2228 sec read

After a five-year wait, C.H. Robinson makes a broker acquisition

C.H. Robinson has acquired DeSpir Logistics, a specialist in secure transportation for high-value freight, marking its first broker acquisition in five years. This move aims to enhance its capabilities in premium, defensible services requiring string...

Ali Nemati

Legal & PolicyJun 2233 sec read

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

A Pennsylvania federal court rejected federal preemption as a defense to terminating a medical marijuana cardholder, holding that Pennsylvania's state protections survive despite federal prohibition and that zero-tolerance policies inadequately addre...

Ali Nemati

CybersecurityJun 1032 sec read

Frasers makes €2 billion offer for Hugo Boss

Frasers Group has announced a voluntary two-billion-euro offer to acquire the remaining outstanding shares of the German luxury apparel firm Hugo Boss to strengthen its premium retail portfolio. The British group already holds a 26 percent stake and ...

Ali Nemati

Legal & PolicyJun 532 sec read

Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products

The Supreme Court unanimously ruled that generic pharmaceutical manufacturers are not liable for patent infringement when doctors or pharmacists independently choose to use generic products for patented indications. This decision establishes a high l...

Ali Nemati

Xpeng committed to Australia despite TrueEV court battle

Related Articles

Almost Half of Americans View SCOTUS as Political

After a five-year wait, C.H. Robinson makes a broker acquisition

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

Frasers makes €2 billion offer for Hugo Boss

Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products